Michel DVM - Siemens Healthineers Pres Therapies
SHL Stock | EUR 52.08 0.08 0.15% |
Insider
Michel DVM is Pres Therapies of Siemens Healthineers AG
Age | 62 |
Phone | 49 9131 84 3385 |
Web | https://www.siemens-healthineers.com |
Siemens Healthineers Management Efficiency
The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1129 %, meaning that it generated $0.1129 on every $100 dollars invested by stockholders. Siemens Healthineers' management efficiency ratios could be used to measure how well Siemens Healthineers manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Yibing Wu | WuXi AppTec Co | 51 | |
Edward MBA | WuXi AppTec Co | 60 | |
Yao Chi | WuXi AppTec Co | 40 | |
Jennifer Honeycutt | Danaher | 53 | |
Mitchell Rales | Danaher | 66 | |
Howard JD | WuXi AppTec Co | N/A | |
Robert McMahon | Agilent Technologies | 54 | |
Darlene Solomon | Agilent Technologies | 64 | |
Brian McKeon | IDEXX Laboratories | 61 | |
Minzhang Chen | WuXi AppTec Co | 53 | |
Kyler Lei | WuXi AppTec Co | N/A | |
Padraig McDonnell | Agilent Technologies | N/A | |
Xiaomeng Tong | WuXi AppTec Co | 45 | |
Rodney Gonsalves | Agilent Technologies | 57 | |
Nimrata PE | IDEXX Laboratories | 55 | |
JoseCarlos GutierrezRamos | Danaher | 59 | |
Michael McMullen | Agilent Technologies | 62 | |
Michael Tang | Agilent Technologies | 49 | |
Martin Smith | IDEXX Laboratories | 55 | |
Ken Grady | IDEXX Laboratories | N/A | |
Christopher Bouda | Danaher | N/A |
Management Performance
Return On Equity | 0.11 | |||
Return On Asset | 0.0383 |
Siemens Healthineers Leadership Team
Elected by the shareholders, the Siemens Healthineers' board of directors comprises two types of representatives: Siemens Healthineers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Siemens. The board's role is to monitor Siemens Healthineers' management team and ensure that shareholders' interests are well served. Siemens Healthineers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Siemens Healthineers' outside directors are responsible for providing unbiased perspectives on the board's policies.
Andre Hartung, Head Imaging | ||
Christian Klaussner, Ex Fin | ||
Carsten Bertram, Head Therapies | ||
Bernhard Montag, CEO Pres | ||
Christopher Toth, Head Varian | ||
Darleen Caron, Labor Officer | ||
Marc Koebernick, Head Relations | ||
Michel DVM, Pres Therapies | ||
Jochen Schmitz, CFO Board | ||
Elisabeth Staudinger, Member Board |
Siemens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Siemens Healthineers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.11 | |||
Return On Asset | 0.0383 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.13 % | |||
Current Valuation | 56.35 B | |||
Shares Outstanding | 1.12 B | |||
Shares Owned By Insiders | 75.30 % | |||
Shares Owned By Institutions | 11.84 % | |||
Price To Earning | 34.79 X | |||
Price To Book | 3.12 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Siemens Stock
Siemens Healthineers financial ratios help investors to determine whether Siemens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Siemens with respect to the benefits of owning Siemens Healthineers security.